Financial results - PHARMALOG EXCELA S.R.L.

Financial Summary - Pharmalog Excela S.r.l.
Unique identification code: 38746998
Registration number: J2018000948400
Nace: 4618
Sales - Ron
220.168
Net Profit - Ron
191.506
Employees
2
Open Account
Company Pharmalog Excela S.r.l. with Fiscal Code 38746998 recorded a turnover of 2024 of 220.168, with a net profit of 191.506 and having an average number of employees of 2. The company operates in the field of Intermedieri în comerţul specializat în vânzarea produselor cu caracter specific, n.c.a. having the NACE code 4618.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharmalog Excela S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - 0 22.278 42.066 77.302 106.062 175.398 220.168
Total Income - EUR - - - 0 22.278 42.066 77.302 106.214 175.398 235.667
Total Expenses - EUR - - - 0 9.835 14.756 19.641 21.478 24.760 38.260
Gross Profit/Loss - EUR - - - 0 12.443 27.310 57.661 84.736 150.638 197.407
Net Profit/Loss - EUR - - - 0 11.775 26.137 56.652 83.676 148.884 191.506
Employees - - - 0 0 1 2 1 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 26.2%, from 175.398 euro in the year 2023, to 220.168 euro in 2024. The Net Profit increased by 43.454 euro, from 148.884 euro in 2023, to 191.506 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharmalog Excela S.r.l.

Rating financiar

Financial Rating -
PHARMALOG EXCELA S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharmalog Excela S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmalog Excela S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmalog Excela S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmalog Excela S.r.l. - CUI 38746998

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - 880 100 29.434 21.274 12.828 5.280 39.101
Current Assets - - - 65 15.606 25.044 54.619 78.339 150.595 179.494
Inventories - - - 22 21 162 158 159 158 0
Receivables - - - 0 15.378 24.357 35.163 70.354 121.689 169.218
Cash - - - 43 206 525 19.298 7.826 28.748 10.276
Shareholders Funds - - - 43 11.859 37.792 56.854 83.879 149.086 191.707
Social Capital - - - 43 84 103 202 203 202 201
Debts - - - 901 3.847 16.686 19.038 8.392 8.376 27.984
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4618 - 4618"
CAEN Financial Year 4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 179.494 euro in 2024 which includes Inventories of 0 euro, Receivables of 169.218 euro and cash availability of 10.276 euro.
The company's Equity was valued at 191.707 euro, while total Liabilities amounted to 27.984 euro. Equity increased by 43.454 euro, from 149.086 euro in 2023, to 191.707 in 2024.

Risk Reports Prices

Reviews - Pharmalog Excela S.r.l.

Comments - Pharmalog Excela S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.